Therapy with rhenium-186 HEDP in painful disseminated bone metastases in breastcancer;SCHMERZTHERAPIE BEI MULTIPLEN KNOCHENMETASTASEN BEI MAMMAKARZINOMEN MIT RHENIUM-186 HEDP

Zentralblatt fur Gynakologie

Volumn 120, Issue 2, 1998, Pages 83-86

  Hauswirth, Alexandra E ^a   Palmedo, H ^a   Dierke Dzierzon, C ^a   Biersack, H J ^a   Krebs, D ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Bone metastases; Breastcancer; Pain therapy; Rhenium 186 HEDP (Hydroxyethylidendiphosphonat

Indexed keywords

ANALGESIC AGENT; ETIDRONIC ACID; RHENIUM 186;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER PAIN; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN;

EID: 0031910920     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Achenbach W: Rationale Praxis-Onkologie. Perimed (1994) 159-176
2. Aziz H, Choi K, Sohn C et al.: Comparison of P-32 therapy and sequential hemibody irradiation for bony metastases as methods of whole-body irradiation. Am J Clin Oncol 9 (1986) 264-268
3. Becker N, Frenzel-Beyme R, Wagner G: Krebsatlas der Bundesrepublik Deutschland. Berlin - Heidelberg - New York: Springer 1984
4. Buchali K, Correns HJ, Schuerer M et al.: Results of a double blind study of strontium-89 therapy of skeletal metastases of prostatic carcinoma. Eur J Nucl Med 14 (1988) 349-351
5. Gilbert HA, Kagan AR, Nussbaum H, Rao AR, Satzman J, Chan P, Forsythe A: Evaluation of radiation therapy for bone metastases: pain relief and quality of live. Am J Roentgenol 129 (1977) 1095-1096
6. Kutzner J, Hahn K, Grimm W et al.: Yttrium-90 Zitat zur Schmerztherapie bei Knochenmetastasen. Nuc compact 21 (1990) 129-132
7. Maxon HR, Deutsch EA, Thomas SR et al.: Re-186 HEDP for treatment of multiple metastatic foci in bone: human bio-distribution and dosimetric studies. Radiology 166 (1988) 501-507
8. Maxon HR, Schroder LE, Thomas SR et al.: Re-186 HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone resistent prostate-cancer. Radiology 176 (1990) 155-159
9. Maxon HR, Deutsch EA, Thomas SR et al.: Rhenium-186 HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies. Radiology 166 (1988) 501-507
10. Maxon HR, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga R, Smith H, Moulton S, Wiliams CC, Ehrhardt GJ, Schneider HJ: Rhenium-186 HEDP for treatment of painful osseous metastases: results of a double blind crossover comparison with placebo. J Nucl Med 32 (1991) 1877-1881
11. Maxon HR, Thomas SR, Hertzberg VS et al.: Rhenium-186 HEDP for the treatment of painful osseous metastases. Sem Nucl Med 22 (1992) 33-40
12. Palmedo H, Meyer G, Dierke-Dzierzon C, Mallmann P, Schoeneich G, Grünwald E, Reichmann K, Bockisch A, Biersack HJ: Re-186 HEDP for palliative Therapy of pain-ful bone metastases. Eur J Nucl Med 21 (1994) 566
13. Porter AT, McEwan AJ: Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays progression in advanced prostate cancer: results of a randomized controlled trial. Sem Oncol (1993) Suppl 2; 38-43
14. Statistisches Bundesamt: Sterbefälle an bösartigen Neubildungen der Brustdrüse Pos.-Nr. 174/175 des früheren Bundesgebietes, Stand 1995
15. Zonnenberg BA, De Klerk JMH, Van Rijk PP et al.: Rhenium-186 HEDP for treatment of painful bone metastases in patients with metastatic prostate or breast cancer. J Nucl Med 32 (1991) 1082